InflaRx N.V.  (NASDAQ:IFRX) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed vilobelimab for SARS-CoV-2-induced acute respiratory distress.

To meet growing demand from its enterprise customers, Lead2Pipeline adds 2 Sales Directors after reviewing more than 900 job applicants. As a leading growth services provider and one of the 5 largest ...

OLB Group, Inc. , a diversified Fintech eCommerce merchant services provider and Bitcoin mining enterprise, announced today its financial results for the three and nine months ending September 30, ...

Serotonin Centers, a leading provider of Medical Spa Services, is thrilled to announce the launch of its new location in St.